硝苯地平缓释片联合依那普利片治疗老年高血压合并冠心病患者的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the therapeutic effects of combination therapy on elderly patients with hypertension and coronary heart disease.MethodsTotally 76 elderly patients with hypertension and coronary heart disease who were treated in our hospital from July 2015 to May 2017 were selected as subjects of this study.The selected patients were randomly divided into experimental group and control group according to the random number table method,38 cases in each group.Patients in the control group were treated with Nifedipine Sustained Release Tablets only.Nifedipine Sustained Release Tablets combined with Enalapril Tablets were used in the experimental group.The total effective rate,systolic and diastolic blood pressure before and after treatment and incidence of adverse reactions during treatment were compared between the two groups.ResultsThe total effective rate in the experimental group was significantly higher than that in the control group,the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in systolic blood pressure and diastolic blood pressure between the two groups(P>0.05).After treatment,the systolic and diastolic blood pressure were significantly lower than before treatment,and the systolic and diastolic blood pressure of patients in the experimental group were significantly lower than those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).ConclusionThe combined treatment of hypertension and coronary heart disease in elderly patients with significant effect,which can quickly stabilize patients with systolic and diastolic blood pressure,improve clinical symptoms,fewer adverse drug reactions,with the promotion of value.

Key words： Elderly hypertension Coronary heart disease Nifedipine Sustained Release Tablets Enalapril Tablets

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIN Su-ping

Cite this article:

QIN Su-ping. Effect of Nifedipine Sustained Release Tablets combined w ith Enalapril Tablets in the treatment of elderly patients w ith hypertension and coronary heart disease[J]. 中国当代医药, 2018, 25(17): 143-145.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I17/143

[1]	郑广生，李宝梅，李垚，等.吲达帕胺联合氨氯地平应用于老年高血压合并冠心病患者的疗效分析[J].中国临床保健杂志，2015，18（6）：621-624.
[2]	梁东亮，李小鹰，王林，等.老年冠心病合并糖尿病及高血压患者降压达标和降压药物使用情况的现况调查[J].中华医学杂志，2015，95（33）：2709-2714.
[3]	王建超，徐扬扬.吲达帕胺联合氨氯地平治疗高血压合并冠心病患者的疗效分析[J].中西医结合心血管病电子杂志，2015，3（19）：64-65.
[4]	中国高血压防治指南修订委员会.中国高血压防治指南（2010）[J].中华心血管病杂志，2011，39（7）：701-708.
[5]	沈迎，张奇，沈卫峰.美国和欧洲稳定性冠心病诊治指南解读[J].中华心血管病杂志，2014，42（1）：70-72.
[6]	杨洋.硝苯地平缓释片联合依那普利治疗老年冠心病合并高血压患者的临床效果[J].中国实用医药，2016，11（12）：145-146.
[7]	Tasic I，Kostic S，Skakic V，et al.AB0832 Increased Serum Uric Acid（SUA）Levels Are A Common Finding in Patients with High Blood Pressure，Insulin Resistance，Obesity and Cardiovascular（CV） Disease[J].Ann Rheum Dis，2016，75（S2）：1188.
[8]	刘彩成，马海娥.氯沙坦联合硝苯地平缓释片治疗原发性高血压的临床疗效[J].实用心脑肺血管病杂志，2017，25（7）：103-105.
[9]	罗良涛，郭淑贞，张鹏，等.冠心病慢性心力衰竭合并高血压患者证候要素和证候分布特点[J].北京中医药大学学报，2017，40（7）：607-612.
[10]	梁东亮，李小鹰，王林，等.门诊老年冠心病合并高血压患者体质指数对血压达标率的影响[J].中华医学杂志，2016，96（35）：2830-2837.
[11]	李晓燕，公雪，张红明，等.奥美沙坦对高血压合并冠心病和糖尿病患者血管内皮功能的保护作用[J].中国动脉硬化杂志，2017，25（2）：181-185.
[12]	党育红.硝苯地平缓释片联合依那普利在老年冠心病合并高血压患者中的应用价值[J].临床医学研究与实践，2017，2（19）：25-26.
[13]	林彩云，陈武，何淑芬.硝苯地平控释片联合缬沙坦治疗老年2型糖尿病肾病合并高血压的效果[J].山东医药，2017，57（5）：84-86.
[15]	王士强，唐杨章，张怀金，等.硝苯地平控释片治疗老年单纯性收缩期高血压的临床研究[J].中国临床药理学杂志，2017，33（14）：1298-1300.
[14]	Wang Y，Su X，Zhang W，et al.Correlation between serum cystatin C level and elderly hypertensive patients combined coronary heart disease[J].Int J Clin Exp Med，2015，8（4）：6287-6290.